The article explores the "injurer-innovator problem," where patent and tort law create conflicting incentives for innovators. It argues that tort law's duty to invest in care can discourage innovation, as the cost of self-implementation may outweigh patent revenues. It propose "anti-patents," a legal concept granting immunity from tort law's heightened standard of care while retaining patent protection.